These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 20095940
1. Integrin targeted drug and gene delivery. Wang Z, Chui WK, Ho PC. Expert Opin Drug Deliv; 2010 Feb; 7(2):159-71. PubMed ID: 20095940 [Abstract] [Full Text] [Related]
5. Nanoparticle and targeted systems for cancer therapy. Brannon-Peppas L, Blanchette JO. Adv Drug Deliv Rev; 2004 Sep 22; 56(11):1649-59. PubMed ID: 15350294 [Abstract] [Full Text] [Related]
6. Layered double hydroxide nanoparticles in gene and drug delivery. Ladewig K, Xu ZP, Lu GQ. Expert Opin Drug Deliv; 2009 Sep 22; 6(9):907-22. PubMed ID: 19686052 [Abstract] [Full Text] [Related]
7. Cationic nanoparticles for cancer therapy. Bilensoy E. Expert Opin Drug Deliv; 2010 Jul 22; 7(7):795-809. PubMed ID: 20446858 [Abstract] [Full Text] [Related]
8. Polymeric micelles as a new drug carrier system and their required considerations for clinical trials. Yokoyama M. Expert Opin Drug Deliv; 2010 Feb 22; 7(2):145-58. PubMed ID: 20095939 [Abstract] [Full Text] [Related]
10. A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles. Li L, Wartchow CA, Danthi SN, Shen Z, Dechene N, Pease J, Choi HS, Doede T, Chu P, Ning S, Lee DY, Bednarski MD, Knox SJ. Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1215-27. PubMed ID: 15001266 [Abstract] [Full Text] [Related]
11. Tumour-targeted drug and gene delivery: principles and concepts. Cassidy J, Schätzlein AG. Expert Rev Mol Med; 2004 Sep 13; 6(19):1-17. PubMed ID: 15387893 [Abstract] [Full Text] [Related]
12. PR_b-targeted PEGylated liposomes for prostate cancer therapy. Demirgöz D, Garg A, Kokkoli E. Langmuir; 2008 Dec 02; 24(23):13518-24. PubMed ID: 18954096 [Abstract] [Full Text] [Related]
13. Nanoparticles in cellular drug delivery. Faraji AH, Wipf P. Bioorg Med Chem; 2009 Apr 15; 17(8):2950-62. PubMed ID: 19299149 [Abstract] [Full Text] [Related]
14. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Winter PM, Neubauer AM, Caruthers SD, Harris TD, Robertson JD, Williams TA, Schmieder AH, Hu G, Allen JS, Lacy EK, Zhang H, Wickline SA, Lanza GM. Arterioscler Thromb Vasc Biol; 2006 Sep 15; 26(9):2103-9. PubMed ID: 16825592 [Abstract] [Full Text] [Related]
15. Targeted delivery of nanoparticles for the treatment of lung diseases. Azarmi S, Roa WH, Löbenberg R. Adv Drug Deliv Rev; 2008 May 22; 60(8):863-75. PubMed ID: 18308418 [Abstract] [Full Text] [Related]
17. Antibody-drug conjugates: targeted drug delivery for cancer. Alley SC, Okeley NM, Senter PD. Curr Opin Chem Biol; 2010 Aug 22; 14(4):529-37. PubMed ID: 20643572 [Abstract] [Full Text] [Related]
18. Avidin-biotin technology in targeted therapy. Lesch HP, Kaikkonen MU, Pikkarainen JT, Ylä-Herttuala S. Expert Opin Drug Deliv; 2010 May 22; 7(5):551-64. PubMed ID: 20233034 [Abstract] [Full Text] [Related]
19. Recent developments in carbohydrate-decorated targeted drug/gene delivery. Zhang H, Ma Y, Sun XL. Med Res Rev; 2010 Mar 22; 30(2):270-89. PubMed ID: 19626595 [Abstract] [Full Text] [Related]